Brian Ko

685 total citations
14 papers, 224 citations indexed

About

Brian Ko is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Brian Ko has authored 14 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Rheumatology. Recurrent topics in Brian Ko's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (3 papers). Brian Ko is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (3 papers). Brian Ko collaborates with scholars based in United States, Australia and Netherlands. Brian Ko's co-authors include Balázs Halmos, Shirish M. Gadgeel, Martin MacDonald, Sándor Kántor, Paul Leong, Mihoko Yamamoto, Thomas E. Scammell, Takatoshi Mochizuki, Naoko Takebe and Chris Arthur and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and SLEEP.

In The Last Decade

Brian Ko

12 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Ko United States	7	70	68	64	39	38	14	224
Haiyan Huang China	9	66 0.9×	48 0.7×	108 1.7×	15 0.4×	47 1.2×	22	259
Azusa Yamato Japan	8	73 1.0×	55 0.8×	207 3.2×	7 0.2×	64 1.7×	12	313
Tianyu Tao China	10	62 0.9×	28 0.4×	174 2.7×	5 0.1×	76 2.0×	23	331
Amélie Forest United States	8	106 1.5×	44 0.6×	161 2.5×	14 0.4×	64 1.7×	10	302
Anna Hellquist Sweden	9	63 0.9×	6 0.1×	58 0.9×	18 0.5×	15 0.4×	9	347
Zhisu Liao China	9	40 0.6×	27 0.4×	255 4.0×	7 0.2×	46 1.2×	16	355
Carole Y. Perrot France	8	102 1.5×	21 0.3×	136 2.1×	14 0.4×	33 0.9×	8	341
Yumei Zhang China	8	80 1.1×	63 0.9×	98 1.5×	18 0.5×	68 1.8×	27	283
Jarred Burkart United States	9	272 3.9×	112 1.6×	130 2.0×	12 0.3×	25 0.7×	19	403
Amy Kluge United States	10	153 2.2×	79 1.2×	163 2.5×	21 0.5×	69 1.8×	13	349

Countries citing papers authored by Brian Ko

Since Specialization

Citations

This map shows the geographic impact of Brian Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Ko more than expected).

Fields of papers citing papers by Brian Ko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Ko. The network helps show where Brian Ko may publish in the future.

Co-authorship network of co-authors of Brian Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Ko. A scholar is included among the top collaborators of Brian Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Ko. Brian Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ko, Brian, Pakdee Rojanasopondist, & William M. Grady. (2025). Top advances of the year: Noninvasive colorectal cancer screening tests. Cancer. 131(20). e70115–e70115.

Tan, Sean, et al.. (2024). An association between Dasatinib, elevated left atrial pressure and pleural effusion. International Journal of Cardiology. 410. 132216–132216. 1 indexed citations

Farooq, Maria, Jibran Ahmed, Brian Ko, et al.. (2024). Blood-based multi-cancer detection: A state-of-the-art update. Current Problems in Cancer. 48. 101059–101059. 6 indexed citations

Ko, Brian, et al.. (2024). Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients. Melanoma Research. 34(2). 134–141. 1 indexed citations

Ko, Brian, et al.. (2023). Rethinking Oncologic Treatment Strategies with Interleukin-2. Cells. 12(9). 1316–1316. 14 indexed citations

Salkeni, Mohamad A., Brian Ko, Brian A. Van Tine, et al.. (2023). A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma.. Journal of Clinical Oncology. 41(16_suppl). 11533–11533. 1 indexed citations

Ko, Brian, Geraldine O’Sullivan Coyne, Abdul Rafeh Naqash, et al.. (2023). Abstract B138: Pharmacodynamics-driven phase 2 trial of talazoparib in patients with advanced solid tumors and aberrations in genes involved in DNA damage response. Molecular Cancer Therapeutics. 22(12_Supplement). B138–B138.

Leong, Paul, et al.. (2019). Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge. The Medical Journal of Australia. 210(9). 417–423. 20 indexed citations

Alexander, Mariam P., Brian Ko, Rémy Lambert, Shirish M. Gadgeel, & Balázs Halmos. (2019). The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancer. Expert Review of Respiratory Medicine. 14(2). 137–147. 5 indexed citations

10.

Oseledchyk, Anton, Jacob Ricca, Mathieu Gigoux, et al.. (2018). Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus. Oncotarget. 9(47). 28702–28716. 27 indexed citations

11.

Ross, David M., Chris Arthur, Kate Burbury, et al.. (2018). Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors. Internal Medicine Journal. 48(S2). 5–13. 20 indexed citations

12.

Ko, Brian, et al.. (2017). MET/HGF pathway activation as a paradigm of resistance to targeted therapies. Annals of Translational Medicine. 5(1). 4–4. 54 indexed citations

13.

Ko, Brian, et al.. (2017). <em>EGFR</em> T790M: revealing the secrets of a gatekeeper. PubMed. Volume 8. 147–159. 34 indexed citations

14.

Kántor, Sándor, et al.. (2013). Orexin Gene Therapy Restores the Timing and Maintenance of Wakefulness in Narcoleptic Mice. SLEEP. 36(8). 1129–1138. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact